# Bioequivalence Pilot Study of Dirithromycin of (Abdi İbrahim İlaç San.Ve.Tic.A.Ş,Turkey) in Healthy Subjects Under Fasting Condition

> **NCT02185833** · PHASE1 · COMPLETED · sponsor: **Pharmaceutical Research Unit, Jordan** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** DIRITHROMYCIN 500 MG ENTERIC COATED TABLET
- **DRUG:** DYNABAC 250 MG ENTERIC COATED TABLET

## Key facts

- **NCT ID:** NCT02185833
- **Lead sponsor:** Pharmaceutical Research Unit, Jordan
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-07-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02185833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02185833, "Bioequivalence Pilot Study of Dirithromycin of (Abdi İbrahim İlaç San.Ve.Tic.A.Ş,Turkey) in Healthy Subjects Under Fasting Condition". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02185833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*